Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients

Background: It has been proposed that Trp (620) allotype of protein tyrosine phosphatases number 22 (PTPN22) gene can intensify the susceptibility to rheumatoid arthritis (RA) and other autoimmune diseases. Thus, in this study, the prevalence of this polymorphism has been surveyed among RA patients...

Full description

Bibliographic Details
Main Authors: Mansour Salesi, Golshan Taghipour Boroujeni, Mansoor Salehi, Hadi Karimzadeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Advanced Biomedical Research
Subjects:
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2014;volume=3;issue=1;spage=218;epage=218;aulast=Salesi
id doaj-3bdec13770c84cbaa27d176b44cfa469
record_format Article
spelling doaj-3bdec13770c84cbaa27d176b44cfa4692020-11-24T22:48:07ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752277-91752014-01-013121821810.4103/2277-9175.143294Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patientsMansour SalesiGolshan Taghipour BoroujeniMansoor SalehiHadi KarimzadehBackground: It has been proposed that Trp (620) allotype of protein tyrosine phosphatases number 22 (PTPN22) gene can intensify the susceptibility to rheumatoid arthritis (RA) and other autoimmune diseases. Thus, in this study, the prevalence of this polymorphism has been surveyed among RA patients compared with healthy persons. The samples were selected from Isfahan province (one of the most populated area of Iran). Materials and Methods: In this study, 100 patients (case group) and 100 healthy persons (control group) were participated voluntarily. The case group was selected from people who had referred to the rheumatology clinic of AlZahra University Hospital to follow-up their treatment and change their drugs dosage. The control group members, who were living in Isfahan province, mutually had similar age with patients. On a total, 22% of the case group was male and 75% of the control group was female. DNA was extracted from the blood sample of all cases and controls and the PTPN22 single nucleotide polymorphism (SNP) C1858> T gene polymorphism were studied using the polymerase chain reaction-restriction fragment length polymorphism method. Results: PTPN22 SNP C1858> T gene polymorphism was observed in 11 persons (11%) of the case group and 8 persons (8%) of the control group. Conclusion: The results show that the difference was not statistically significant in Isfahan RA population (P = 0.47; OR = 1.42; 95% CI 0.55-3.69). Although, another study on Iranian population had shown that this polymorphism confers susceptibility to RA.http://www.advbiores.net/article.asp?issn=2277-9175;year=2014;volume=3;issue=1;spage=218;epage=218;aulast=SalesiIsfahanpolymorphismprotein tyrosine phosphates number 22rheumatoid arthritis
collection DOAJ
language English
format Article
sources DOAJ
author Mansour Salesi
Golshan Taghipour Boroujeni
Mansoor Salehi
Hadi Karimzadeh
spellingShingle Mansour Salesi
Golshan Taghipour Boroujeni
Mansoor Salehi
Hadi Karimzadeh
Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients
Advanced Biomedical Research
Isfahan
polymorphism
protein tyrosine phosphates number 22
rheumatoid arthritis
author_facet Mansour Salesi
Golshan Taghipour Boroujeni
Mansoor Salehi
Hadi Karimzadeh
author_sort Mansour Salesi
title Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients
title_short Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients
title_full Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients
title_fullStr Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients
title_full_unstemmed Assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: A study on Iranian patients
title_sort assessment of protein tyrosine phosphatases number 22 polymorphism prevalence among rheumatoid arthritis patients: a study on iranian patients
publisher Wolters Kluwer Medknow Publications
series Advanced Biomedical Research
issn 2277-9175
2277-9175
publishDate 2014-01-01
description Background: It has been proposed that Trp (620) allotype of protein tyrosine phosphatases number 22 (PTPN22) gene can intensify the susceptibility to rheumatoid arthritis (RA) and other autoimmune diseases. Thus, in this study, the prevalence of this polymorphism has been surveyed among RA patients compared with healthy persons. The samples were selected from Isfahan province (one of the most populated area of Iran). Materials and Methods: In this study, 100 patients (case group) and 100 healthy persons (control group) were participated voluntarily. The case group was selected from people who had referred to the rheumatology clinic of AlZahra University Hospital to follow-up their treatment and change their drugs dosage. The control group members, who were living in Isfahan province, mutually had similar age with patients. On a total, 22% of the case group was male and 75% of the control group was female. DNA was extracted from the blood sample of all cases and controls and the PTPN22 single nucleotide polymorphism (SNP) C1858> T gene polymorphism were studied using the polymerase chain reaction-restriction fragment length polymorphism method. Results: PTPN22 SNP C1858> T gene polymorphism was observed in 11 persons (11%) of the case group and 8 persons (8%) of the control group. Conclusion: The results show that the difference was not statistically significant in Isfahan RA population (P = 0.47; OR = 1.42; 95% CI 0.55-3.69). Although, another study on Iranian population had shown that this polymorphism confers susceptibility to RA.
topic Isfahan
polymorphism
protein tyrosine phosphates number 22
rheumatoid arthritis
url http://www.advbiores.net/article.asp?issn=2277-9175;year=2014;volume=3;issue=1;spage=218;epage=218;aulast=Salesi
work_keys_str_mv AT mansoursalesi assessmentofproteintyrosinephosphatasesnumber22polymorphismprevalenceamongrheumatoidarthritispatientsastudyoniranianpatients
AT golshantaghipourboroujeni assessmentofproteintyrosinephosphatasesnumber22polymorphismprevalenceamongrheumatoidarthritispatientsastudyoniranianpatients
AT mansoorsalehi assessmentofproteintyrosinephosphatasesnumber22polymorphismprevalenceamongrheumatoidarthritispatientsastudyoniranianpatients
AT hadikarimzadeh assessmentofproteintyrosinephosphatasesnumber22polymorphismprevalenceamongrheumatoidarthritispatientsastudyoniranianpatients
_version_ 1725679628440305664